Swedish Orphan Biovitrum AB (publ) /
CTI BioPharma Corp.
Swedish Orphan Biovitrum AB (publ) completes purchase of CTI BioPharma Corp.
- Price
- USD 1.7bn
- Stage
- Closed
What happened
Swedish Orphan Biovitrum AB (publ) completed its acquisition of CTI BioPharma Corp. for up to USD 1.7 billion (approximately SEK 17.1 billion), according to a filing dated June 26, 2023.
The source
Everything on this page comes from the source below.
Swedish Orphan Biovitrum AB (publ) completes purchase of CTI BioPharma Corp.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly